Peter H. Griffith serves as the Executive Vice President and Chief Financial Officer at Amgen Inc., a leading biotechnology company focused on developing innovative treatments for serious illnesses. With a robust background in finance and strategic leadership, Griffith has been instrumental in steering Amgen's financial strategies and ensuring the company's growth and sustainability. Before joining Amgen, he held several high-profile positions in the financial sector, which equipped him with the expertise necessary to manage the complex financial landscape of a global biotechnology firm. Griffith's career spans over three decades, during which he has demonstrated a keen ability to navigate the intricacies of corporate finance. Prior to his current role at Amgen, he served as the CFO at another major corporation, where he successfully implemented cost-saving initiatives and improved operational efficiencies. His strategic foresight and meticulous attention to detail have been pivotal in his ability to drive Amgen's financial performance. Under his leadership, Amgen has seen significant improvements in its financial health, enabling the company to invest in groundbreaking research and development projects. As the EVP and CFO at Amgen, Peter H. Griffith is responsible for overseeing the company's global finance operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. His role is crucial in ensuring that Amgen remains financially robust while continuing to innovate in the biotechnology field. Griffith's strategic vision and leadership have not only solidified Amgen's position as a leader in the industry but also fostered a culture of financial discipline and accountability within the organization. His contributions have been widely recognized, and he continues to play a vital role in shaping the future of Amgen.